MX2024008276A - Metodos para sintetizar compuestos de 1h-furo[3,2-b]imidazo[4,5-d] piridina. - Google Patents

Metodos para sintetizar compuestos de 1h-furo[3,2-b]imidazo[4,5-d] piridina.

Info

Publication number
MX2024008276A
MX2024008276A MX2024008276A MX2024008276A MX2024008276A MX 2024008276 A MX2024008276 A MX 2024008276A MX 2024008276 A MX2024008276 A MX 2024008276A MX 2024008276 A MX2024008276 A MX 2024008276A MX 2024008276 A MX2024008276 A MX 2024008276A
Authority
MX
Mexico
Prior art keywords
compound
furo
imidazo
synthesizing
methods
Prior art date
Application number
MX2024008276A
Other languages
English (en)
Spanish (es)
Inventor
Congxin Liang
Shuangjiang Li
Junmin Huang
Guoqiang Shi
Yaya Duan
Pucha Yan
Original Assignee
Hangzhou Highlightll Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Highlightll Pharmaceutical Co Ltd filed Critical Hangzhou Highlightll Pharmaceutical Co Ltd
Publication of MX2024008276A publication Critical patent/MX2024008276A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
MX2024008276A 2021-12-30 2022-12-19 Metodos para sintetizar compuestos de 1h-furo[3,2-b]imidazo[4,5-d] piridina. MX2024008276A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111658903.5A CN114213424B (zh) 2021-12-30 2021-12-30 一种呋喃[3,2-b]并吡啶衍生物的合成方法
PCT/CN2022/139966 WO2023125102A1 (zh) 2021-12-30 2022-12-19 1H-呋喃并[3,2-b]咪唑并[4,5-d]吡啶化合物的合成方法

Publications (1)

Publication Number Publication Date
MX2024008276A true MX2024008276A (es) 2024-09-02

Family

ID=80707144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024008276A MX2024008276A (es) 2021-12-30 2022-12-19 Metodos para sintetizar compuestos de 1h-furo[3,2-b]imidazo[4,5-d] piridina.

Country Status (10)

Country Link
US (1) US20250171458A1 (cg-RX-API-DMAC10.html)
EP (1) EP4509509A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024546195A (cg-RX-API-DMAC10.html)
KR (1) KR20240129021A (cg-RX-API-DMAC10.html)
CN (2) CN114213424B (cg-RX-API-DMAC10.html)
AU (1) AU2022426316A1 (cg-RX-API-DMAC10.html)
CA (1) CA3244846A1 (cg-RX-API-DMAC10.html)
IL (1) IL313966A (cg-RX-API-DMAC10.html)
MX (1) MX2024008276A (cg-RX-API-DMAC10.html)
WO (1) WO2023125102A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201990523A1 (ru) 2016-10-03 2019-10-31 НОВЫЕ СЕЛЕКТИВНЫЕ ИНГИБИТОРЫ Jak1 И ИХ ПРИМЕНЕНИЕ
CN114213424B (zh) * 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3,2-b]并吡啶衍生物的合成方法
WO2025224600A1 (en) * 2024-04-21 2025-10-30 Biohaven Therapeutics Ltd. Treatment of alpha-synucleinopathies and neuroprotection
CN121949334A (zh) * 2024-10-30 2026-05-01 谱尼生物医药科技(上海)有限公司 一种医药中间体7-羟基呋喃并[3,2-b]吡啶的合成方法及其中间体化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007039146A1 (en) * 2005-09-23 2007-04-12 Smithkline Beecham Corporation 4-carboxy pyrazole derivatives as anti-viral agents
WO2011138657A1 (en) * 2010-05-04 2011-11-10 Glenmark Pharmaceuticals S.A. Aryl substituted olefinic compounds as pde10a inhibitors
WO2013051672A1 (ja) * 2011-10-04 2013-04-11 株式会社ヤクルト本社 チアゾリジン誘導体又はその塩を有効成分とする医薬品
CN103450125B (zh) * 2013-07-18 2016-01-13 嘉兴中科化学有限公司 一种5-取代苯丙呋喃-2-羧酸及其衍生物的合成方法
EP2940022B1 (en) * 2014-04-30 2020-09-02 Masarykova Univerzita Furopyridines as inhibitors of protein kinases
CN105418620B (zh) * 2014-09-23 2018-05-04 天津药明康德新药开发有限公司 一种4-(叔丁氧羰基)八氢呋喃并[3,2-b]吡啶-6-羧酸的合成方法
WO2016100349A2 (en) * 2014-12-16 2016-06-23 Rugen Holdings (Cayman) Limited Bicyclic azaheterocyclic compounds as nr2b nmda receptor antagonists
WO2016196244A1 (en) * 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
CN106432232A (zh) * 2016-09-18 2017-02-22 苏州汉德创宏生化科技有限公司 1‑哌啶‑4‑基‑1,3‑二氢‑咪唑[4,5‑b]吡啶‑2‑酮的合成方法
EA201990523A1 (ru) * 2016-10-03 2019-10-31 НОВЫЕ СЕЛЕКТИВНЫЕ ИНГИБИТОРЫ Jak1 И ИХ ПРИМЕНЕНИЕ
CN107216334A (zh) * 2017-06-29 2017-09-29 上海吉尔多肽有限公司 一种6‑氯呋喃[3,2‑b]吡啶的合成方法
MX2021014319A (es) 2019-06-06 2022-01-26 Highlightll Pharmaceutical Hainan Co Ltd Metodo de sintesis del compuesto de furoimidazopiridina, forma de cristal del compuesto de furoimidazopiridina, y forma de cristal de la sal del mismo.
EP4393492A3 (en) 2019-06-06 2024-08-07 Hangzhou Highlightll Pharmaceutical Co., Ltd. Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt
EP3967694A4 (en) * 2019-06-06 2022-12-07 Beijing Tide Pharmaceutical Co., Ltd. 2, 4, 6-TRI-SUBSTITUTED PYRIMIDINE COMPOUND AS ATR-KINASE INHIBITOR
WO2021061803A1 (en) * 2019-09-23 2021-04-01 Nanjing Zhengxiang Pharmaceuticals Co., Ltd. Phosphodiesterase inhibitors and use
CA3162572A1 (en) * 2019-11-27 2021-06-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Tri-heterocyclic compound as jak inhibitor, and use thereof
CN114213424B (zh) * 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3,2-b]并吡啶衍生物的合成方法

Also Published As

Publication number Publication date
EP4509509A4 (en) 2026-06-03
WO2023125102A1 (zh) 2023-07-06
CA3244846A1 (en) 2025-06-13
CN114213424A (zh) 2022-03-22
CN114213424B (zh) 2023-05-26
US20250171458A1 (en) 2025-05-29
JP2024546195A (ja) 2024-12-17
KR20240129021A (ko) 2024-08-27
IL313966A (en) 2024-08-01
EP4509509A1 (en) 2025-02-19
AU2022426316A1 (en) 2024-07-25
CN118679166A (zh) 2024-09-20

Similar Documents

Publication Publication Date Title
EP3398952A1 (en) Synthesis process of ruxolitinib
ES2923278T3 (es) Intermedios útiles para la síntesis de derivados de aminopirimidinas, proceso de preparación del mismo y proceso de preparación de aminopirimidina derivados utilizando los mismos
PH12012502363A1 (en) Process for the preparation of dihydropyrrole derivatives
MX2024004146A (es) Metodo de sintesis del compuesto de furoimidazopiridina, forma de cristal del compuesto de furoimidazopiridina, y forma de cristal de la sal del mismo.
EP2985286B1 (en) Midbody of ticagrelor and preparation method therefor, and preparation method for ticagrelor
EP0705262A1 (en) Process for asymmetric total synthesis of camptothecin
Tran et al. An efficient method of synthesis of isoxazolidine-fused β-lactams via base-promoted cyclization–ring opening of carbamoyl-spirocyclopropane isoxazolidines
AU6474200A (en) Process for the preparation of a pyridinemethanol compound
Jin et al. Iodine-promoted imino-Diels–Alder reaction of fluorinated imine with enol ether: synthesis of 2-perfluorophenyl tetrahydroquinoline derivatives
Richichi et al. Stereoselective synthesis of new bicyclic N, O-iso-homonucleoside analogues
Wang et al. A unified and straightforward total synthesis of (+)-porantheridine and (−)-6-epi-porantheridine
Hachiya et al. Synthesis of nitrogen-containing heterocycles using conjugate addition reactions of nucleophiles to α, β-unsaturated imines
Risitano et al. Pyridinium N-ylides and (arylmethylene) azol-5-ones. Reaction cascade leading to an unusual spiroisoxazolinone ring
Quan et al. Efficient synthesis of 5H‐thiazolo [3, 2‐a] pyrimidines from reactions of 3, 4‐dihydropyrimidine‐thiones with α‐bromoacetone in aqueous media
Kobayashi et al. Synthesis of the proposed structure of phaeosphaeride A
Mohammadizadeh et al. A novel one-pot and efficient procedure for the synthesis of 3H-spiro [isobenzofuran-1, 6′-pyrrolo [2, 3-d] pyrimidine]-2′, 3, 4′, 5′-tetraones
TW200604161A (en) Chemical process
Acosta et al. Rational use of substituted N-allyl and N, N-diallylanilines in the stereoselective synthesis of novel 2-alkenyltetrahydro-1-benzazepines
EP2595994B1 (en) Process for preparing pyrano - [2,3-c]pyridine derivatives
Bakulina et al. Synthesis of novel peri-fused heterocyclic systems—pyrimido [4, 5, 6-de][1, 8] naphthyridines, based on interaction of 4, 6-dichloro-2-methylthiopyrimidine-5-carbaldehyde with geminal enediamines
Kakoi Synthesis of 2-Amino-3-benzyl-5-(p-hydroxyphenyl) pyrazine
Dekić et al. Synthesis of new condensed and cyclized coumarin derivatives
Basabe et al. Synthesis of spongidines A and D: marine metabolites phospholipase A2 inhibitors
JP2003012670A (ja) 抗菌活性を有する4−オキソキノリジン系化合物
Sato et al. Photoinduced Electron Transfer-Initiated Selective Cyclization Reactions of (Z)-N-Benzoyl-α-dehydro-(1-naphthyl) alaninamides into 4, 5-Dihydrooxazole Derivatives